Physician profile
Dylan Ross Pearson
NPI 1346531753
$5,400.13
in general payments reported to CMS, 2019-2025
15 companies · $3,051 in 2025
The $3,051 reported for 2025 was more than what 90% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.21 · 2022: $392 · 2023: $1,431 · 2024: $432 · 2025: $3,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,908 · Food and Beverage: $2,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,908.41 |
| Food and Beverage | $2,005.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,090.24 | 2025 | Indigo System |
| Pulmonx Corporation | $1,308.57 | 2022-2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Getinge USA Sales, LLC | $677.71 | 2025 | Vasoview Hemopro 2 |
| Astrazeneca Pharmaceuticals LP | $453.31 | 2021-2025 | Breztri, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $205.47 | 2021-2025 | Nucala |
| Abiomed | $144.83 | 2023 | Impella |
| Genzyme Corporation | $125.04 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $116.52 | 2022-2025 | Dupixent |
| Philips North America LLC | $90.57 | 2023-2024 | (Ak6) Vest Therapy |
| Electromed, INC. | $58.43 | 2025 | Smartvest |
| Grifols USA, LLC | $39.40 | 2024-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $31.66 | 2024 | Glassia, Aralast |
| Verona Pharma, INC. | $28.89 | 2025 | Ohtuvayre |
| Alexion Pharmaceuticals, INC. | $15.94 | 2021 | |
| Mylan Specialty L.P. | $13.55 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.